Safety and Effectiveness of PCSK9 Inhibitors in Orthotopic Heart Transplant Patients

被引：0
|
作者：
Sammour, Yasser [1 ]
Austin, Bethany A. [1 ]
Borkon, Michael [1 ]
Everley, Mark P. [1 ]
Fendler, Timothy J. [1 ]
Khumri, Taiyeb M. [1 ]
Lawhorn, Stephanie L. [1 ]
Magalski, Anthony [1 ]
Nassif, Michael E. [1 ]
Vodnala, Deepthi [1 ]
Kao, Andrew C. [1 ]
Sperry, Brett W. [1 ]
机构：
[1] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
来源：
JOURNAL OF CARDIAC FAILURE | 2020年 / 26卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
054
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Pcsk9 Inhibitors In Heart Transplant Patients: Safety, Efficacy And Nonresponse
    Abou Hassan, Ossama K.
    Anderson, Keith G.
    Albert, Chonyang L.
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 565 - 565
  • [2] PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates
    Sammour, Yasser
    Dezorzi, Christopher
    Austin, Bethany A.
    Borkon, A. Michael
    Everley, Mark P.
    Fendler, Timothy J.
    Khumri, Taiyeb M.
    Lawhorn, Stephanie L.
    Nassif, Michael E.
    Vodnala, Deepthi
    Magalski, Anthony
    Kao, Andrew C.
    Sperry, Brett W.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (07) : 812 - 815
  • [3] Immunologic Response to PCSK9 Inhibitors in Orthotopic Heart Transplant Recipients: A Case Series
    Bikak, Abdul L.
    Berei, Theodore
    Nissen-Boryczka, Karen
    Dhingra, Ravi
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S27 - S27
  • [4] Safety and Efficacy of PCSK9 Inhibitor Treatment in Heart Transplant Patients
    Di Nora, Concetta
    Sponga, Sandro
    Livi, Ugolino
    TRANSPLANTATION, 2019, 103 (03) : E58 - E58
  • [5] PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort
    Vicente-Valor, Juan
    Garcia-Gonzalez, Xandra
    Ibanez-Garcia, Sara
    Duran-Garcia, Maria Esther
    de Lorenzo-Pinto, Ana
    Rodriguez-Gonzalez, Carmen
    Mendez-Fernandez, Irene
    Percovich-Hualpa, Juan Carlos
    Herranz-Alonso, Ana
    Sanjurjo-Saez, Maria
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 146
  • [6] Safety of PCSK9 inhibitors
    Grzesk, Grzegorz
    Dorota, Bednarska
    Wolowiec, Lukasz
    Wolowiec, Anna
    Osiak, Joanna
    Kozakiewicz, Mariusz
    Banach, Joanna
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [7] Safety and Efficacy of PCSK9 Inhibitors After Heart Transplantation
    Moayedi, Yasbanoo
    Kozuszko, Stella
    Knowles, Joshua W.
    Chih, Sharon
    Oro, Gabriela
    Lee, Roy
    Fearon, William F.
    Ross, Heather J.
    Teuteberg, Jeffrey J.
    Khush, Kiran K.
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (01) : 104.e1 - 104.e3
  • [8] Optimization of Hypercholesterolemia Treatment after Heart Transplant: The Role of PCSK9 Inhibitors
    Valero-Masa, Maria Jesus
    Ortiz-Bautista, Carlos David
    Castrodeza, Javier
    Martinez-Selles, Manuel
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (35) : 2797 - 2800
  • [9] PCSK9 inhibitors
    Farnier, Michel
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
  • [10] PCSK9 inhibitors
    Farnier, Michel
    CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (03) : 251 - 258
12345